DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,819,642 | +808.5% | 43,610 | +778.9% | 0.81% | +864.3% |
| Q2 2023 | $1,190,880 | -94.6% | 4,962 | -94.4% | 0.08% | -71.9% |
| Q1 2023 | $22,211,781 | -26.8% | 88,128 | -22.9% | 0.30% | -33.3% |
| Q4 2022 | $30,328,747 | -99.9% | 114,267 | +11.3% | 0.45% | +10.9% |
| Q3 2022 | $26,511,403,000 | -3.1% | 102,642 | -4.9% | 0.40% | +13.2% |
| Q2 2022 | $27,367,991,000 | -23.8% | 107,952 | -11.9% | 0.36% | -13.3% |
| Q1 2022 | $35,935,565,000 | -12.0% | 122,509 | -1.3% | 0.41% | -2.6% |
| Q4 2021 | $40,833,759,000 | +4.5% | 124,111 | -3.3% | 0.42% | +1.2% |
| Q3 2021 | $39,086,138,000 | -23.4% | 128,387 | -32.5% | 0.42% | -18.4% |
| Q2 2021 | $51,024,361,000 | +1.2% | 190,134 | -15.1% | 0.51% | -7.9% |
| Q1 2021 | $50,404,416,000 | +0.8% | 223,940 | -0.5% | 0.56% | -1.9% |
| Q4 2020 | $50,003,048,000 | -3.8% | 225,097 | -6.8% | 0.57% | -19.5% |
| Q3 2020 | $51,987,983,000 | +10.6% | 241,434 | -9.2% | 0.70% | +0.4% |
| Q2 2020 | $47,024,402,000 | +19.8% | 265,930 | -6.3% | 0.70% | +3.5% |
| Q1 2020 | $39,262,903,000 | +19.3% | 283,671 | +32.3% | 0.68% | +60.0% |
| Q4 2019 | $32,899,511,000 | +7.4% | 214,357 | +1.1% | 0.42% | -0.7% |
| Q3 2019 | $30,624,936,000 | -22.1% | 212,040 | -22.9% | 0.43% | -29.1% |
| Q2 2019 | $39,325,724,000 | +68.7% | 275,159 | +55.9% | 0.60% | +56.1% |
| Q1 2019 | $23,307,603,000 | +90.2% | 176,546 | +48.6% | 0.38% | +84.2% |
| Q4 2018 | $12,253,750,000 | +16.6% | 118,830 | +22.9% | 0.21% | +16.1% |
| Q3 2018 | $10,505,792,000 | +6.5% | 96,685 | -3.3% | 0.18% | -5.3% |
| Q2 2018 | $9,866,521,000 | -8.4% | 99,985 | -9.2% | 0.19% | -11.6% |
| Q1 2018 | $10,776,464,000 | +23.7% | 110,065 | +17.3% | 0.22% | +8.6% |
| Q4 2017 | $8,712,549,000 | -6.0% | 93,865 | -13.1% | 0.20% | -2.9% |
| Q3 2017 | $9,269,816,000 | +0.6% | 108,065 | -1.0% | 0.20% | +0.5% |
| Q2 2017 | $9,212,350,000 | -38.6% | 109,164 | -37.8% | 0.20% | +69.2% |
| Q1 2017 | $15,012,739,000 | +2.8% | 175,526 | -2.7% | 0.12% | -13.0% |
| Q4 2016 | $14,602,443,000 | -1.8% | 180,332 | -4.9% | 0.14% | -14.3% |
| Q3 2016 | $14,869,250,000 | +48.9% | 189,683 | +85.3% | 0.16% | +47.7% |
| Q2 2016 | $9,987,837,000 | +21.0% | 102,355 | +17.6% | 0.11% | +21.1% |
| Q1 2016 | $8,255,381,000 | +113.8% | 87,027 | +109.4% | 0.09% | +109.3% |
| Q4 2015 | $3,860,928,000 | +9.9% | 41,569 | +0.8% | 0.04% | +10.3% |
| Q3 2015 | $3,513,550,000 | +118.5% | 41,234 | +119.5% | 0.04% | +143.8% |
| Q2 2015 | $1,607,979,000 | -68.5% | 18,787 | -63.3% | 0.02% | -63.6% |
| Q1 2015 | $5,099,110,000 | +13.0% | 51,179 | -2.8% | 0.04% | +2.3% |
| Q4 2014 | $4,511,260,000 | +8.5% | 52,634 | -3.9% | 0.04% | +4.9% |
| Q3 2014 | $4,159,297,000 | -26.5% | 54,742 | -23.8% | 0.04% | -25.5% |
| Q2 2014 | $5,658,246,000 | +45.9% | 71,869 | +39.0% | 0.06% | +34.1% |
| Q1 2014 | $3,877,950,000 | +5.0% | 51,706 | +8.1% | 0.04% | -2.4% |
| Q4 2013 | $3,692,013,000 | +10.6% | 47,824 | -0.7% | 0.04% | 0.0% |
| Q3 2013 | $3,338,873,000 | +3.1% | 48,163 | -6.3% | 0.04% | -14.3% |
| Q2 2013 | $3,236,978,000 | – | 51,382 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |